Browse by UCL people
Group by: Type | Date
Number of items: 10.
Article
Attard, G;
Murphy, L;
Clarke, NW;
Sachdeva, A;
Jones, C;
Hoyle, A;
Cross, W;
... McPhail, N; + view all
(2023)
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
The Lancet Oncology
, 24
(5)
pp. 443-456.
10.1016/S1470-2045(23)00148-1.
|
 |
|
Clarke, Caroline S;
Hunter, Rachael M;
Gabrio, Andrea;
Brawley, Christopher D;
Ingleby, Fiona C;
Dearnaley, David P;
Matheson, David;
... James, Nicholas D; + view all
(2022)
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
PLoS One
, 17
(6)
, Article e0269192. 10.1371/journal.pone.0269192.
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... STAMPEDE investigators; + view all
(2020)
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.
[Corrigendum].
Annals of Oncology
, 31
(3)
p. 442.
10.1016/j.annonc.2020.01.002.
|
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... James, ND; + view all
(2019)
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of Oncology
10.1093/annonc/mdz396.
(In press).
|
|
James, Nicholas D;
Tannock, Ian;
N'Dow, James;
Feng, Felix;
Gillessen, Silke;
Ali, Syed Adnan;
Trujillo, Blanca;
... Xie, Li-Ping; + view all
(2024)
The Lancet Commission on prostate cancer: planning for the surge in cases.
The Lancet
10.1016/S0140-6736(24)00651-2.
(In press).
|
|
Joharatnam-Hogan, N;
Hochhauser, D;
Shiu, K-K;
Rush, H;
Crolley, V;
Wilson, W;
Sharma, A;
... Khan, K; + view all
(2020)
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Therapeutic Advances in Medical Oncology
pp. 1-9.
10.1177/1758835920956803.
|
|
Meade, Angela;
Frangou, Elena;
Choodari-Oskooei, Babak;
Larkin, James;
Powles, Tom;
Stewart, Grant D;
Albiges, Laurence;
... Parmar, Mahesh KB; + view all
(2024)
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.
Contemporary Clinical Trials Communications
, 42
, Article 101381. 10.1016/j.conctc.2024.101381.
|
 |
|
Parker, Chris C;
James, Nicholas D;
Brawley, Christopher D;
Clarke, Noel W;
Ali, Adnan;
Amos, Claire L;
Attard, Gerhardt;
... Sydes, Matthew R; + view all
(2022)
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Medicine
, 19
(6)
, Article e1003998. 10.1371/journal.pmed.1003998.
|
|
South, Annabelle;
Torras, Berta Terre;
Rush, Hannah;
Goodman, Anna;
Love, Sharon;
(2025)
Developing a knowledge transfer and exchange strategy for a clinical trials unit.
Trials
, 26
(1)
, Article 3. 10.1186/s13063-024-08681-x.
|
|
Thesis
|
Rush, Hannah Louise;
(2023)
Factors that influence choice between treatment options in men with hormone-sensitive prostate cancer.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
